muscle envelope company limited
muscle envelope company limited Company Information
Company Number
03950310
Next Accounts
Aug 2025
Shareholders
the encore group (envelopes & packaging) limited
john russell croisdale
View AllGroup Structure
View All
Industry
Non-trading company
Registered Address
wessyngton house, industrial road, washington, tyne and wear, NE37 2SA
Website
theencoregroup.co.ukmuscle envelope company limited Estimated Valuation
Pomanda estimates the enterprise value of MUSCLE ENVELOPE COMPANY LIMITED at £950 based on a Turnover of £1.7k and 0.58x industry multiple (adjusted for size and gross margin).
muscle envelope company limited Estimated Valuation
Pomanda estimates the enterprise value of MUSCLE ENVELOPE COMPANY LIMITED at £0 based on an EBITDA of £0 and a 4.07x industry multiple (adjusted for size and gross margin).
muscle envelope company limited Estimated Valuation
Pomanda estimates the enterprise value of MUSCLE ENVELOPE COMPANY LIMITED at £8.2k based on Net Assets of £6.1k and 1.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Muscle Envelope Company Limited Overview
Muscle Envelope Company Limited is a live company located in washington, NE37 2SA with a Companies House number of 03950310. It operates in the non-trading company sector, SIC Code 74990. Founded in March 2000, it's largest shareholder is the encore group (envelopes & packaging) limited with a 91.7% stake. Muscle Envelope Company Limited is a mature, micro sized company, Pomanda has estimated its turnover at £1.7k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Muscle Envelope Company Limited Health Check
Pomanda's financial health check has awarded Muscle Envelope Company Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
4 Weak
Size
annual sales of £1.7k, make it smaller than the average company (£3.4m)
- Muscle Envelope Company Limited
£3.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.3%)
- Muscle Envelope Company Limited
5.3% - Industry AVG
Production
with a gross margin of 34.3%, this company has a comparable cost of product (34.3%)
- Muscle Envelope Company Limited
34.3% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Muscle Envelope Company Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (41)
- Muscle Envelope Company Limited
41 - Industry AVG
Pay Structure
on an average salary of £40.2k, the company has an equivalent pay structure (£40.2k)
- Muscle Envelope Company Limited
£40.2k - Industry AVG
Efficiency
resulting in sales per employee of £1.7k, this is less efficient (£148.6k)
- Muscle Envelope Company Limited
£148.6k - Industry AVG
Debtor Days
it gets paid by customers after 40 days, this is near the average (40 days)
- Muscle Envelope Company Limited
40 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Muscle Envelope Company Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Muscle Envelope Company Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Muscle Envelope Company Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24.8%, this is a lower level of debt than the average (47.1%)
24.8% - Muscle Envelope Company Limited
47.1% - Industry AVG
MUSCLE ENVELOPE COMPANY LIMITED financials
Muscle Envelope Company Limited's latest turnover from November 2023 is estimated at £1.7 thousand and the company has net assets of £6.1 thousand. According to their latest financial statements, we estimate that Muscle Envelope Company Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | |||||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 184 | ||||||
| Group Debtors | 7,885 | 7,885 | 7,885 | 7,885 | 7,885 | 7,885 | 7,885 | 7,885 | 7,885 | ||||||
| Misc Debtors | |||||||||||||||
| Cash | |||||||||||||||
| misc current assets | |||||||||||||||
| total current assets | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | ||||||
| total assets | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | 8,069 | ||||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | ||||||
| total current liabilities | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | ||||||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | ||||||
| net assets | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | ||||||
| total shareholders funds | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 | 6,069 |
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 8,069 | ||||||||||||||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | 2,000 | ||||||||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
muscle envelope company limited Credit Report and Business Information
Muscle Envelope Company Limited Competitor Analysis
Perform a competitor analysis for muscle envelope company limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in NE37 area or any other competitors across 12 key performance metrics.
muscle envelope company limited Ownership
MUSCLE ENVELOPE COMPANY LIMITED group structure
Muscle Envelope Company Limited has no subsidiary companies.
Ultimate parent company
1 parent
MUSCLE ENVELOPE COMPANY LIMITED
03950310
muscle envelope company limited directors
Muscle Envelope Company Limited currently has 4 directors. The longest serving directors include Mr Craig Allen (Feb 2021) and Mr Mark Eyeington (Feb 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Craig Allen | 42 years | Feb 2021 | - | Director | |
| Mr Mark Eyeington | 50 years | Feb 2021 | - | Director | |
| Mr Gary Joyce | 40 years | Feb 2021 | - | Director | |
| Mr David Cooper | 49 years | Feb 2021 | - | Director |
P&L
November 2023turnover
1.7k
+4%
operating profit
0
0%
gross margin
34.3%
+4.73%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
6.1k
0%
total assets
8.1k
0%
cash
0
0%
net assets
Total assets minus all liabilities
muscle envelope company limited company details
company number
03950310
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
March 2000
age
25
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
November 2023
previous names
N/A
accountant
BROWN BUTLER
auditor
-
address
wessyngton house, industrial road, washington, tyne and wear, NE37 2SA
Bank
-
Legal Advisor
-
muscle envelope company limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to muscle envelope company limited.
muscle envelope company limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MUSCLE ENVELOPE COMPANY LIMITED. This can take several minutes, an email will notify you when this has completed.
muscle envelope company limited Companies House Filings - See Documents
| date | description | view/download |
|---|
